In 2023, South Korean pharmaceutical company Yuhan's sales revenue from prescription drugs amounted to around 1.14 trillion South Korean won. This represents a slight increase from the previous year.
Sales revenue of Yuhan Co., Ltd. from prescription (ETC) drugs from 2016 to 2023 (in billion South Korean won)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Net income Yuhan 2015-2022
- Premium Statistic Operating income Yuhan 2015-2022
- Premium Statistic Sales revenue from medicine raw material exports Yuhan 2016-2023
- Premium Statistic Sales revenue from non-prescription drugs Yuhan 2016-2022
- Basic Statistic Sales value of nonprescription pharmaceuticals in Norway 2017-2021
- Premium Statistic Sales revenue distribution Yuhan 2022, by sector
- Premium Statistic Pharmaceutical self-care companies in Sweden 2018, by sales value
- Premium Statistic Revenue from pharmaceutical manufacturer in Denmark 2009-2023
- Premium Statistic Chemicals and pharma consumption in Russia 2021, by segment
- Basic Statistic Number of applications for clinical trials in Norway 2008-2021
About the region
10
- Premium Statistic Yuhan Chemical's sales revenue 2016-2019
- Premium Statistic Sales revenue Hanmi Pharmaceutical 2017-2023
- Premium Statistic Net profit Hanmi Pharmaceutical 2017-2022
- Premium Statistic R&D investment Beijing Hanmi Pharmaceutical 2017-2022
- Premium Statistic R&D investment Hanmi Fine Chemical 2017-2022
- Premium Statistic R&D investment Hanmi Pharmaceutical 2017-2022
- Premium Statistic Sales revenue Hanmi Pharmaceutical 2017-2022
- Premium Statistic Sales revenue Yuhan 2015-2023
- Premium Statistic Yuhan-Kimberly's sales revenue 2016-2019
- Premium Statistic Yuhan-Kimberly's net profit 2016-2019
Selected statistics
10
- Basic Statistic Sanofi's total assets 2007-2023
- Premium Statistic Pfizer's revenues in the U.S. and abroad 2009-2023
- Premium Statistic AstraZeneca's expenditure on research and development 2006-2023
- Premium Statistic Johnson & Johnson's number of employees 2004-2023
- Premium Statistic Sales of Johnson & Johnson worldwide 2011-2023, by segment
- Premium Statistic Sales of Johnson & Johnson 2006-2023 by region
- Basic Statistic Merck & Co cash dividends declared 2006-2023
- Premium Statistic Merck & Co - expenditure on research and development 2006-2023
- Basic Statistic Merck & Co total assets 2009-2023
- Basic Statistic GSK's operating profit by division 2006-2021
Other regions
10
- Premium Statistic Revenue of the vitamins & minerals industry in Italy 2017-2028
- Basic Statistic Revenue of pharmaceutical company Recordati 2022, by product
- Basic Statistic Expenditure on pharmaceuticals in Sweden 2009-2023
- Basic Statistic Number of applications for drug reimbursement in Denmark 2013-2022
- Basic Statistic Largest nonprescription pharmaceutical companies in Norway 2021, by market share
- Premium Statistic Employment in pharma industry in Colombia 2014-2020
- Premium Statistic Pharmacy count in Russia 2020-2021, by e-commerce permit
- Premium Statistic Unit market share of vitamins sold in Spain by company 2019-2020
- Premium Statistic Genomma Lab: headcount 2015-2019
- Premium Statistic Prices of leading laxative/stimulant liquid/powder/oil brands in the U.S. 2019
Related statistics
10
- Premium Statistic Market share of Celltrion's Remsima in Europe Q1 2015-Q2 2018
- Premium Statistic Market share of Celltrion's Truxima in Europe Q2 2017-Q2 2018
- Premium Statistic Leading countries for pharmaceutical exports South Korea 2022, by export value
- Premium Statistic Leading countries for pharmaceutical imports South Korea 2022, by import value
- Premium Statistic Prescription drug products production value South Korea 2012-2022
- Premium Statistic Sales revenue Celltrion 2013-2022
- Premium Statistic Parenteral nutrition company market share in South Korea 2015
- Premium Statistic Sales revenue of JW Pharmaceutical 2014-2022
- Premium Statistic Operating profit of JW Pharmaceutical 2014-2022
- Premium Statistic R&D spending of JW Pharmaceutical South Korea 2014-2022
Further related statistics
10
- Pfizer's ad spending 2006-2023
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- Number of employees at Sinopharm 2011-2022
- Annual revenue of Sinopharm 2010-2022
- Annual revenue of Shanghai Pharmaceuticals 2011-2022
- R&D expenditure in U.S. biotechnology 2009-2010 by type
- Walgreens gross profit and net earnings in the U.S. 2005-2023
- Revenue of Sinopharm 2011-2022, by category
- Celgene's revenue and net income 2006-2018
- Key figures on established biotech centers worldwide 2012-2016
Further Content: You might find this interesting as well
Statistics
- Pfizer's ad spending 2006-2023
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- Number of employees at Sinopharm 2011-2022
- Annual revenue of Sinopharm 2010-2022
- Annual revenue of Shanghai Pharmaceuticals 2011-2022
- R&D expenditure in U.S. biotechnology 2009-2010 by type
- Walgreens gross profit and net earnings in the U.S. 2005-2023
- Revenue of Sinopharm 2011-2022, by category
- Celgene's revenue and net income 2006-2018
- Key figures on established biotech centers worldwide 2012-2016
DART. (March 7, 2024). Sales revenue of Yuhan Co., Ltd. from prescription (ETC) drugs from 2016 to 2023 (in billion South Korean won) [Graph]. In Statista. Retrieved May 16, 2024, from https://www.statista.com/statistics/975539/yuhan-sales-revenue-prescription-drugs/
DART. "Sales revenue of Yuhan Co., Ltd. from prescription (ETC) drugs from 2016 to 2023 (in billion South Korean won)." Chart. March 7, 2024. Statista. Accessed May 16, 2024. https://www.statista.com/statistics/975539/yuhan-sales-revenue-prescription-drugs/
DART. (2024). Sales revenue of Yuhan Co., Ltd. from prescription (ETC) drugs from 2016 to 2023 (in billion South Korean won). Statista. Statista Inc.. Accessed: May 16, 2024. https://www.statista.com/statistics/975539/yuhan-sales-revenue-prescription-drugs/
DART. "Sales Revenue of Yuhan Co., Ltd. from Prescription (Etc) Drugs from 2016 to 2023 (in Billion South Korean Won)." Statista, Statista Inc., 7 Mar 2024, https://www.statista.com/statistics/975539/yuhan-sales-revenue-prescription-drugs/
DART, Sales revenue of Yuhan Co., Ltd. from prescription (ETC) drugs from 2016 to 2023 (in billion South Korean won) Statista, https://www.statista.com/statistics/975539/yuhan-sales-revenue-prescription-drugs/ (last visited May 16, 2024)
Sales revenue of Yuhan Co., Ltd. from prescription (ETC) drugs from 2016 to 2023 (in billion South Korean won) [Graph], DART, March 7, 2024. [Online]. Available: https://www.statista.com/statistics/975539/yuhan-sales-revenue-prescription-drugs/